ATI Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 3

ATI General Information

Description

Operator of a drug discovery company intended to treat organ fibrosis and solid cancers. The company utilizes integrin-targeting technology to produce humanized integrin inhibitor antibodies, enabling medical researchers to address cancer conditions with advanced therapeutics.

Contact Information

Website
www.integrin.jp
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1-5-44 Kairouen
  • Saeki-ku
  • Hiroshima, 731-5135
  • Japan
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 1-5-44 Kairouen
  • Saeki-ku
  • Hiroshima, 731-5135
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ATI Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 27-Oct-2024 Completed Pre-Clinical Trials
2. Seed Round 23-Jul-2024 Completed Pre-Clinical Trials
1. Accelerator/Incubator 01-Jan-2023 Completed Startup
To view ATI’s complete valuation and funding history, request access »

ATI Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
J-Startup West Accelerator/Incubator
Mitsubishi UFJ Capital Venture Capital Minority
Nedo (Accelerator) Accelerator/Incubator
To view ATI’s complete investors history, request access »

Ready to get started?

Request a free trial

ATI FAQs

  • When was ATI founded?

    ATI was founded in 2022.

  • Where is ATI headquartered?

    ATI is headquartered in Hiroshima, Japan.

  • What industry is ATI in?

    ATI’s primary industry is Drug Discovery.

  • Is ATI a private or public company?

    ATI is a Private company.

  • What is ATI’s current revenue?

    The current revenue for ATI is .

  • Who are ATI’s investors?

    J-Startup West, Mitsubishi UFJ Capital, and Nedo (Accelerator) have invested in ATI.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process